Correlation Between Roche Holding and ASTELLAS PHARMA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Roche Holding and ASTELLAS PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roche Holding and ASTELLAS PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roche Holding Ltd and ASTELLAS PHARMA UNSPADR, you can compare the effects of market volatilities on Roche Holding and ASTELLAS PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roche Holding with a short position of ASTELLAS PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roche Holding and ASTELLAS PHARMA.

Diversification Opportunities for Roche Holding and ASTELLAS PHARMA

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Roche and ASTELLAS is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Roche Holding Ltd and ASTELLAS PHARMA UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASTELLAS PHARMA UNSPADR and Roche Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roche Holding Ltd are associated (or correlated) with ASTELLAS PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASTELLAS PHARMA UNSPADR has no effect on the direction of Roche Holding i.e., Roche Holding and ASTELLAS PHARMA go up and down completely randomly.

Pair Corralation between Roche Holding and ASTELLAS PHARMA

Assuming the 90 days trading horizon Roche Holding Ltd is expected to under-perform the ASTELLAS PHARMA. But the stock apears to be less risky and, when comparing its historical volatility, Roche Holding Ltd is 1.03 times less risky than ASTELLAS PHARMA. The stock trades about -0.26 of its potential returns per unit of risk. The ASTELLAS PHARMA UNSPADR is currently generating about -0.21 of returns per unit of risk over similar time horizon. If you would invest  1,020  in ASTELLAS PHARMA UNSPADR on August 29, 2024 and sell it today you would lose (85.00) from holding ASTELLAS PHARMA UNSPADR or give up 8.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Roche Holding Ltd  vs.  ASTELLAS PHARMA UNSPADR

 Performance 
       Timeline  
Roche Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
ASTELLAS PHARMA UNSPADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Roche Holding and ASTELLAS PHARMA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Roche Holding and ASTELLAS PHARMA

The main advantage of trading using opposite Roche Holding and ASTELLAS PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roche Holding position performs unexpectedly, ASTELLAS PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASTELLAS PHARMA will offset losses from the drop in ASTELLAS PHARMA's long position.
The idea behind Roche Holding Ltd and ASTELLAS PHARMA UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities